NCT04616157

Brief Summary

The primary objective of this study is to test the feasibility and efficacy of Internet-delivered Cognitive Behavioral Therapy (CBT) for adolescents (13 - 17 years) with sleep problems (ICBT-I). All participants will receive ICBT-I for six weeks. The investigators will also evaluate the effect of the intervention on comorbid psychiatric symptoms and function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 4, 2020

Completed
Last Updated

November 4, 2020

Status Verified

October 1, 2020

Enrollment Period

1.3 years

First QC Date

April 5, 2018

Last Update Submit

October 30, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in insomnia symptom severity

    Insomnia Severity Index- adolescent version ISI is a seven-item measure that yields a quantitative index of sleep impairment and treatment outcome. Total scores range from 0 to 28, with higher scores indicating greater perceived insomnia severity. The instrument has been adapted to teenagers, ISI-a, and validated on Swedish teenagers.

    Change from before treatment to after (+6 weeks) and to 6 month after treatment

Secondary Outcomes (17)

  • Change in subjective total sleep time

    Change from before treatment to after (+6 weeks) and to 6 month after treatment

  • Change in subjective sleep onset latency

    Change from before treatment to after (+6 weeks) and to 6 month after treatment

  • Change in subjective wake after sleep onset

    Change from before treatment to after (+6 weeks) and to 6 month after treatment

  • Change in subjective sleep efficiency

    Change from before treatment to after (+6 weeks) and to 6 month after treatment

  • Change in objective sleep total sleep time

    Change from before treatment to after (+6 weeks) and to 6 month after treatment

  • +12 more secondary outcomes

Study Arms (1)

ICBT-I

EXPERIMENTAL

The ICBT-I treatment program is a web-based intervention consisting of six chapters/sessions that adolescents go through during six consecutive weeks.The program starts with psychoeducation regarding sleep disorders and the rationale for a cognitive behavioral intervention. The main focus for the treatment is behavioral interventions, mainly sleep restriction and stimulus control. The intervention also addresses problem solving, maintenance of treatment gains, relapse prevention and relaxation techniques. Caregivers will not actively participate in the treatment. During the treatment phase participants will be in contact with a therapist through standardized forms in the program.

Behavioral: ICBT-I

Interventions

ICBT-IBEHAVIORAL

Cognitive-behavioral therapy for insomnia

ICBT-I

Eligibility Criteria

Age13 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Clinical levels of insomnia symptoms, as determined by ISI-a \>10.
  • Age between 13 and 17 years
  • Ability to read and write Swedish
  • Daily access to the internet through a computer or similar device
  • Participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment

You may not qualify if:

  • Diagnosed with autism spectrum disorder, psychosis or bipolar disorder
  • Present risk of suicide
  • Ongoing substance dependence
  • Completed CBT for sleep disorders within the last 6 months (defined as at least 5 sessions of CBT
  • Ongoing use of central nervous system stimulant medication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BUP KFE

Stockholm, 11364, Sweden

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersDepressive DisorderAnxiety DisordersChronic PainInflammation

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersMood DisordersPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Study Officials

  • Mats Lekander, PhD

    Karolinska Institutet

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All participants will receive treatment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 5, 2018

First Posted

November 4, 2020

Study Start

September 1, 2018

Primary Completion

December 31, 2019

Study Completion

July 1, 2020

Last Updated

November 4, 2020

Record last verified: 2020-10

Locations